SynthesisFrontiers in clinical diabetes and healthcare2026
User experiences and perceptions on the use of digital health technologies in the management of type 2 diabetes: an integrative systematic review.
Synthesis in Frontiers in clinical diabetes and healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Type 2 diabetes mellitus (T2DM) represents a global public health problem. In Ecuador, it is the second leading cause of death among women and the third among men. Digital health technologies, including mobile applications, messaging platforms, and web-based tools, have emerged as promising interventions for managing this condition, although a gap remains between their theoretical potential and their effective implementation in clinical practice. Objective: To explore and synthesize the available evidence on the experiences, perceptions, barriers, and facilitators reported by adult users with type 2 diabetes mellitus regarding the use of digital health technologies for managing their disease in community or outpatient settings. Methodology: An integrative systematic review of literature published between 2015 and 2025 was conducted in PubMed, Scopus, and Google Scholar. Qualitative, quantitative, and mixed-methods studies in English and Spanish involving adults using mobile applications for T2DM were included. Methodological quality was assessed using the Johns Hopkins Evidence-Based Practice model. Results: A total of 66 studies were analyzed, with qualitative designs predominating (n=28), followed by randomized clinical trials (n=13) and experimental studies (n=14). Most studies were rated as high (n=35) or good quality (n=28). Experiences were grouped into three categories: positive (usefulness, satisfaction, empowerment, educational support), conditioning factors (individual, contextual, and design-related), and barriers (technological, usability, personal). Perceptions focused on usefulness, usability, and impact on self-care. Facilitators included simple design, personalization, professional support, cultural adequacy, and motivation. Conclusions: Digital health technologies promote self-management and glycemic control, although barriers persist that limit their sustained adoption. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251241989.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.